[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100615312":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":30,"responsibleParty":54,"collaborators":58,"id":65,"slug":66,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":67,"sex":73,"minAge":10,"maxAge":10,"enrollmentInfo":74,"targetDuration":77,"studyType":78,"phases":10,"briefSummary":79,"conditions":80,"keywords":85,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Tata Memorial Hospital","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients diagnosed with Cervical Cancer",null,"Patients diagnosed with histologically proven cervical cancer wherein either radical, adjuvant or palliative radiation with or without concurrent or systemic chemotherapy planned.",[13],"Other: Not applicable- observational study",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"OTHER","Not applicable- observational study","Compliance to Cervical Cancer Chemoradiation treatment guidelines",[9],[21],{"name":22,"affiliation":23,"role":24},"Dr. Supriya Chopra, MD","ACTREC, Tata Memorial Centre, Navi Mumbai India","PRINCIPAL_INVESTIGATOR",[26],{"name":22,"role":27,"phone":28,"phoneExt":10,"email":29},"CONTACT","9930958309","supriyasastri@gmail.com",[31,46],{"facility":5,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Mumbai","Maharashtra","400012","India","IN",{"type":39,"coordinates":40},"Point",[41,42],72.88261,19.07283,{"lat":42,"lon":41},[45],{"name":22,"role":27,"phone":28,"phoneExt":10,"email":29},{"facility":5,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":47,"geoPoint":49,"contacts":50},{"type":39,"coordinates":48},[41,42],{"lat":42,"lon":41},[51],{"name":52,"role":27,"phone":53,"phoneExt":10,"email":29},"Dr Supriya Chopra, MD","+91 9930958309",{"type":24,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":57,"oldNameTitle":10,"oldOrganization":10},"Supriya Sastri (chopra)","Professor Dr Supriya Sastri","Tata Memorial Centre",[59,61,63],{"name":60,"class":16},"Post Graduate Institute of Medical Education and Research, Chandigarh",{"name":62,"class":6},"MNJ Institute of Oncology and Regional Cancer Center",{"name":64,"class":16},"Christian Medical College, Vellore, India","100615312","compliance-to-cervical-cancer-chemoradiation-guidelines-a-multicentric-implementation-audit-and-resource-assessment-initiative-of-national-cancer-grid-of-india-100615312",false,"NCT07290972","Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India","Compliance to Cervical Cancer Chemoradiation Guidelines: A Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India","NCG-Compliance","The participating centers that agree to contribute data will include all registered cases over a 6 month period that have been diagnosed with histologically proven cervical cancer wherein either radical, adjuvant or palliative radiation with or without concurrent or systemic chemotherapy is planned.\n\nFurthermore any cases referred to the institution for brachytherapy alone will also be included.","FEMALE",{"count":75,"type":76},618,"ESTIMATED","3 Years","OBSERVATIONAL","This is a combination of retrospective and prospective observational study that will be performed across NCG and other participating centers to report compliance to chemoradiation for cervical cancer. This audit will include patients treated with standard of care treatment, in this case definitive or adjuvant radiation+\u002F- concurrent chemotherapy will be included. Patients recruited in various institutions in prospective clinical trials will not be included. The participating centersthat agree to contribute data will include all registered cases over a 6-month period that have been diagnosed with cervical cancer wherein treatment is planned with radical dose radiation and\u002For concurrent chemotherapy. Centers that do not have retrospective data of the patients will contribute data of patients registered prospectively over 6 months. Furthermore, any cases referred to the institution for brachytherapy alone will also be included.\n\nAs a first step member institutions that participated in guideline development process or provide an agreement to guidelines adherence will be audited. The project will be submitted in institutional ethics committees with memorandum of understanding for anonymized data sharing.\n\nEach of the co-investigators listed from contributing centers will be directly responsible for collecting data contribution and accuracy of data submitted.\n\nThose centres which cannot or do not want to participate will be requested to provide data on only compliance outcomes to treatment for at least of 5 consecutively patients diagnosed with cervical cancer wherein treatment is planned with radical dose radiation and \u002For concurrent chemotherapy over a period of 6 months.",[81,82,83,84],"Cervical Cancer Screening","Gynecologic Cancers","Treatment Compliance","Chemoradiotherapy",[86,87,88,89,90,84],"Cervical cancer","Cancer","Recurrence","Treatment","Compliance","2026-02-03",{"date":93,"type":94},"2026-02-04","ACTUAL",{"date":96,"type":94},"2021-02-01",{"date":98,"type":76},"2026-03-31",{"name":5,"class":6},2]